Biopharma News
Top Biopharma News
-
News Innovation in Drug Delivery & Portfolio Renovation with Sofgen Pharmaceuticals
The Pharma industry is expected to reach $1.9Tn in revenue by 2027, increasing at a rate of 3-6% per year, according to IQVIA1, with some regions being driven by volume, and others by innovation. Growth in developed economies is projected to be slow, w... -
News Fully biodegradable nutraceutical packaging an industry first
An agreement signed between TricorBraun and BioBottles will give nutraceutical companies (and potentially pharmaceutical companies) in the US and Canada access to the industry’s first fully biodegradable packaging option.
Biopharma news
-
News Vetter joins United Nations Global Compact Network
Vetter (Ravensbury, Germany), the aseptic filling and packaging CDMO has signed up to the UN Global Compact Network. -
News Oxfordshire vaccine manufacturing site part of 10-year agreement between Moderna and UK government
In an effort to protect against potential future global health emergencies, the government of the UK and Moderna have cemented a 10-year partnership for vaccine manufacturing and research. -
Sponsored Content How healthcare trends inform dosage forms
Capsules encompass one of the most popular solid oral dosage forms for pharmaceutical products, with the global empty capsule market predicted to rise to USD $3.7 billion by 2026. The growth in the capsule market can be partly attributed to the many op... -
News Women in Pharma – Sukhada Chaturvedi Pharmapack 2023
This year at Pharmapack 2023, we interviewed several leading women in the pharmaceutical industry about what it means to be a woman working in pharma. In the lead-up to International Women’s Day on March 8, 2023, CPHI Online is proud to highlight... -
News 100 years of pharmaceutical packaging excellence - Pharmapack 2023 Premium Partner interview
West Pharmaceutical Services, Inc. speaks to CPHI Online about celebrating their 100-year anniversary as an industry leader, and how they plan to continue driving innovation after the challenges posed from global disruptions in the last few years. -
News Gender equity in pharma - celebrating historic women in pharma
As we continue to celebrate the contributions of women in the pharmaceutical field following International Day of Women and Girls in Science and in the lead up to International Women’s Day on March 8, 2023, we take a look at some of the historic ... -
News Gender equity in pharma– beyond the boardroom
Three reasons why advancing gender equity in healthcare should be a priority for pharma -
News Gilead Sciences’ breast cancer drug receives US FDA approval for third indication
Trodelvy, an antibody–drug conjugate with indications against certain types of cancer, has been approved by the US FDA for a third indication against pre-treated HR+/HER2- metastatic breast cancer. -
News The HPAPI supply chain: why manufacturers should care about handling and transportation
An increasing number of drug development pipelines are turning towards the use of HPAPIs to target rare and ‘undruggable’ diseases. In this article, we talk to leading industry experts about how pharmaceutical manufacturers are adapting and... -
News CARBOGEN AMCIS opens new liquid drug product manufacturing facility
The Switzerland-based pharmaceutical process and ingredient developer and manufacturer announced the opening of their new sterile liquid drug product manufacturing facility in France. -
News 2023 Lunar New Year Round-up: Biopharma in the APAC region
With the Lunar New Year ushering in celebrations for the pharmaceutical community around the world on Sunday January 22, 2023, we’ve rounded up some of the top CPHI Online articles and reports from the last year looking at pharmaceutical markets ... -
News Sai Life Sciences opens new HPAPI manufacturing facility in Bidar, India
A new HPAPI development and manufacturing block is now open at Sai Life Sciences’ Bidar Manufacturing Campus, expanding the CRDMO’s capabilities in small molecule discovery and commercialisation. -
News Anima Biotech brings mRNA biology modulators to AbbVie against oncology and immunology targets
A USD $42 million collaboration between AbbVie and Anima Biotech aims to leverage the latter’s mRNA Lightning technology platform to enhance therapeutic development programs in oncology and immunology. -
News Samsung Biologics Awarded the Terra Carta Seal for Ensuring a Sustainable Future
Samsung Biologics has been awarded The Terra Carta Seal from the sustainable markets initiative. -
News A United Cause: strategic partnership between BioNTech and the Government of the UK announced
A multi-year collaboration between BioNTech and the Government of the United Kingdom will see the expansion of the company’s presence in the UK, focusing on areas like cancer immunotherapies and infectious disease vaccines. -
News Algorithm accelerated: machine-learning may reduce drug formulation development times
Machine-learning models demonstrate the potential to accelerate drug formulation discovery and development for long-acting injectables. -
News CordenPharma signs billion dollar agreement to manufacture new peptide
CordenPharma, the CDMO specialising in APIs, lipid excipients, and drug products, signs a new billion dollar contract to expand its manufacturing capabilities. -
.png)
News Moderna to buy OriCiro Genomics in USD $85 million deal
Pharmaceutical company Moderna acquires genomics services company OriCiro Genomics, based in Tokyo, Japan, to boost mRNA therapeutics development and manufacturing portfolio. -
News New year, new prices: at least 350 drugs in USA to see price increases in January
Drugmakers such as Pfizer, GSK, BMS, AstraZeneca, and Sanofi are planning to raise prices for at least 350 unique drugs in the United States in early January. -
Sponsored Content 2023 Pharma Trend Outlook: Innovation, Resilience, and Pharma 4.0
Download our 2023 Pharma Trends Outlook report to discover the trends set to shape the pharmaceutical landscape in the new year, with expert opinions and insight from across the pharmaceutical value chain. -
.png)
News Strategic partnership between AstraZeneca and G42 Healthcare to increase pharmaceutical manufacturing in Abu Dhabi
A comprehensive, long-term partnership agreement between AstraZeneca and G42 Healthcare is set to enhance local drug manufacturing in Abu Dhabi, UAE, and bolster pharmaceutical manufacturing innovation within the country. -
News CordenPharma joins sustainability initiative to achieve Net Zero
The CDMO has joined the environmental initiative looking to align private sector companies with those aims upheld by the Paris Agreement to reduce global warming. -
News AstraZeneca acquires Neogene in shift into cell-based cancer therapies
AstraZeneca has recently announced that it will be acquiring the biotechnology company Neogene Therapeutics as part of it’s expansion into cell-based cancer treatments.
-
News A mRNA universal flu vaccine is in early stages of development
Researchers from the University of Pennsylvania have developed a universal flu vaccine using nanoparticle encapsulated mRNA. -
.png)
News Biovac partnership to increase African vaccine manufacturing capabilities
South African biopharma company Biovac signs a partnership deal with the International Vaccine Institute to develop and manufacture an oral cholera vaccine for both the African and global market. -
.png)
News New vaccine technology utilising weakened DNA viruses
A new method of vaccine technology that employs weakened viruses has been developed to target DNA viruses that reproduce by making copies of their own DNA molecules, utilising a virus with altered DNA to fight against them. -
News Double threat: new drug shows potential against both COVID-19 and cancer
Researchers have investigated and reported on the potential of GRP78 inhibitors in both reducing the spread of SARS-CoV-2 and as a treatment for certain types of cancers. -
News Lukang Pharma has launched two new products: Tulathromycin and Levodopa
Shandong Lukang Pharmaceutical Co., Ltd is a leading bio-pharmaceutical enterprise in China. -
News Sandoz to invest EUR €50 million in Austrian manufacturing facility for essential antibiotics
Sandoz, a leader in generic pharmaceutical and biosimilars, have announced their intentions to invest EUR €50 million in support of a technology upgrades at their Austrian manufacturing site to support increasing penicillin demands. -
News Blood cancer drug from GSK fails main goal of trial
GSK has released a statement on the failure of Blenrep in achieving the main goals of a late-stage study for the blood cancer therapeutic, raising concerns of regulatory approval being rescinded. -
News Lassa virus antibody cocktail could be the first step in developing a vaccine
A research team from La Jolla Institute for Immunology in California, USA, have identifed a trio of antibodies that could be used to neutralize the Lassa virus -
News A Comprehensive Pharmaceutical Enterprise with Multi-Field
We are committed to the export of several API and intermediates, such as Azathioprine, Mercaptopurine, Ribavirin etc. -
News Expansion of Quotient Sciences’ Alnwick, UK manufacturing facility complete
The major expansion of Quotient Sciences’ drug substance manufacturing facility in Alnwick has been completed, promising increased manufacturing systems and capabilities. -
News LG Chem to acquire AVEO Oncology with USD $566 million investment
South Korean chemical company LG Chem is set to acquire AVEO Oncology, an oncology-focused biopharmaceutical company based in the USA, as part of an investment to increase its footprint in North America and expand its development and commercialisation ... -
News Purolite celebrates expansion of innovative bioprocessing facility in Wales
Purolite, an Ecolab company, marked the opening of a new Customer Experience Centre featuring hands-on interactive and educational displays, showcasing the company’s expanded bioprocessing solutions. -
News ChargePoint Technology and STERIS collaborate to bring sterile solutions for Evonik
Evonik will be provided with sterile solutions from a collaboration between ChargePoint Technology Group and STERIS, utilising ChargePoint’s AseptiSafe Bio Valve and STERIS’ bio-decontamination systems. -
News BioNTech to set up mRNA manufacturing hubs in Australia
BioNTech, co-developers of one of the first mRNA COVID-19 vaccines, have signed an agreement to create manufacturing hubs in and around the Australian Victoria state in a bid to increase the country’s mRNA manufacturing abilities. -
News Provention Bio, Inc. and Sanofi collaboration for potential launch of Type I diabetes therapeutic
Provention Bio, Inc. have granted exclusive right of first negotiation to Sanofi in exchange for commercial resources in the United States for the potential approval and launch of monoclonal antibody therapeutic teplizumab. -
News Merck opens latest 2,700 square metre commercial facility in France
Merck opens their latest commercial manufacturing facility in Martillac, France, boasting rapid development and commercialisation of drug products with streamlined processes and state-of-the-art technology. -
.png)
News Roquette expands plant-based excipient portfolio with Crest Cellulose acquisition
Crest Cellulose, an Indian excipient manufacturer, has been acquired by plant-based pharmaceutical excipient provider Roquette in a bid to increase the latter’s presence in the Asia Pacific region. -
News Greener and efficient processes: Quaternary Ammonium Salts
Quaternary Ammonium Salts play a crucial part in Organic Chemistry processes at many major industries. Discover why.
-
News UK-based partnership to launch DETERMINE study into rare cancer research
UK-based CRO Quanticate is set to partner with Cancer Research UK for the launch of the DETERMINE study focused on testing a range of existing and approved drugs and therapies on rare cancers. -
News MedPharm and Mosanna collaboration to develop novel Metabolic Obstructive Sleep Apnea treatment
A collaboration between development and manufacturing services company MedPharm and biotech company Mosanna aims to develop and deliver a nasal spray treatment for a form of sleep apnea. -
.png)
News Partnership between Bora Pharmaceuticals and TaiRx, Inc. for anticancer drug manufacturing
A partnership between Bora Pharmaceuticals and TaiRx, Inc. is expected to support the manufacturing of breakthrough anticancer drug CVM-1118, with two phase II clinical trials to commence. -
.png)
News Expansion of Quotient Sciences' UK drug development and manufacturing facilities
Quotient Sciences’ Nottingham and Reading facilities have announced the completion of their facility expansions, providing further capabilities to support their flagship program Translational Pharmaceutics®. -
News The Korean biopharma market: Incentivizing innovation
With new drug approvals hitting a record high in 2021 and unprecedented number of out-licensing deals closed in 2020, Korean pharmaceutical companies and CDMO’s are poised for significant market growth [i]. -
News Biden's $2 billion Biotech Boost
President Biden issues executive order to bolster U.S. biomanufacturing sector. -
News Phase III trials of Pfizer’s mRNA-based influenza vaccine begin
Leveraging their current mRNA vaccine technology developed during the COVID-19 pandemic, Pfizer have announced the start of phase III trials for a potential mRNA-based influenza vaccine. -
News mRNA therapy for ovarian cancer and muscle wasting
Researchers demonstrate results of a promising mRNA therapy for ovarian cancer and muscle wasting caused by cachexia, a condition associated with various types of cancers and chronic diseases. -
.png)
News Bora Pharmaceuticals expands development and manufacturing capacity with landmark acquisition
Taiwan-based CDMO Bora Pharmaceuticals have acquired niche generic drugs developer TWi Pharmaceuticals, expanding their outsourced development and manufacturing services with two additional manufacturing facilities. -
News Pfizer CentreOne Content Refinement Q3 media buy
For 40 years Pfizer CentreOne has been guiding drug projects to success. Here’s how our services make us an altogether different kind of CDMO: -
.png)
News Lonza and Touchlight collaboration to bring expanded end-to-end mRNA offerings
Through a collaboration with biotech company Touchlight, Lonza is set to expand their end-to-end offering for mRNA manufacturing with additional DNA raw material sources, including Touchlight’s doggybone DNA. -
.png)
News Oxford University presents promising phase II data for malaria vaccine
The malaria vaccine R21/Matrix-M, developed by researchers at Oxford University, has produced encouraging new data for the global effort against the mosquito-borne disease. -
News NextPharma to acquire Norway manufacturing site from Takeda
Biopharmaceutical company Takeda and CDMO NextPharma have announced an acquisition agreement in which Takeda will divest from their Asker, Norway manufacturing site, set to be acquired by NextPharma. -
.png)
News Gut instinct: molecular link between COVID-19 and serotonin cells in the gut
New research may provide further evidence of the gut’s role in SARS-CoV-2 infection and disease severity with a molecular link between serotonin-producing cells in the gut and COVID-19 disease severity. -
.png)
News Novavax COVID-19 vaccine receives backing from European Medicines Agency
The European Medicines Agency has backed the Nuvaxovid COVID-19 vaccine for adults as a booster shot to other COVID-19 vaccines. -
.png)
News First treatment for Acid Sphingomyelinase Deficiency approved by US FDA
Enzyme replacement therapeutic Xenpozyme has received US FDA approval with an orphan drug designation to treat symptoms of Acid Sphingomyelinase Deficiency, a rare genetic disease. -
News Moderna sues Pfizer/BioNTech over COVID-19 vaccine patent infringement
The pharmaceutical companies behind the leading COVID-19 vaccines are in a legal dispute over intellectual property rights surrounding the mRNA vaccines that were released after emergency use authorization in December 2020. -
News ChargePoint Technology acquires PuroVaso for greater range of powder and liquid transfer solutions
ChargePoint Technology has acquired PuroVaso, leader in the design, development, and manufacture of single-use containers, handling equipment, and accessories for pharma, biopharma, and life sciences. -
News Lonza adds X-ray powder diffraction to micronisation portfolio in Monteggio (CH)
Lonza expands solid-state characterisation services for polymorph and solid-state properties of APIs with the addition of X-ray powder diffraction to its portfolio. -
News Thermo Fisher Scientific expands viral vector manufacturing capabilities with Plainville facility
Thermo Fisher Scientific’s new Plainville, MA viral vector manufacturing facility has opened, expanding the company's cell and gene therapy capabilities with advancing bioproduction and analytical instrumentation technologies. -
News Biosimilars save patients $11B annually, but barriers to adoption remain in US market
Biosimilars introduce competition into the biologics market, driving down prices and increasing patient access. -
News WHO recommends use of two monoclonal antibody treatments against Ebola
The health body recommended use of treatments by Regeneron and Ridgeback Bio -
News $475 million acquisition of Metrics Contract Services by Catalent Inc.
Catalent Inc. is set to acquire Metrics Contract Services in a USD $475 million bid to expand its high-potent capacities and oral development and manufacturing capabilities by the end of 2022 -
News Breaking the ground for WuXi STA’s new pharmaceutical facility in Delaware
WuXi AppTec subsidiary and leading CRDMO, WuXi STA, has broken the ground at the site for its new 190-acre pharmaceutical manufacturing campus in Middletown, Delaware. -
News New dual-action vaccine against original SARS-CoV-2 strain and Omicron variant
Moderna’s novel bivalent vaccine is the first of its kind to be approved by the UK Medicines and Healthcare Products Regulatory Agency in the fight against the COVID-19 pandemic and SARS-CoV-2 variants. -
News Collaboration to advance manufacturing of regenerative medicine and biotherapeutics
A collaboration between Mayo Clinic and National Resilience Inc. hopes to advance the biomanufacturing and delivery of novel biologic therapeutics for rare and complex conditions. -
News Establishment of antiviral development centre for pandemic-level viruses
Researchers across several US institutions will come together to establish a centre for the research and development of antiviral drugs and therapeutics against pandemic-level viruses. -
News Strategic partnership to rapidly bring monkeypox test kits to market
A strategic partnership between WeTrade Group and Jiqing Biomedical Technology hopes to rapidly bring monkeypox virus test kits to market and open antigen test sale channels. -
News Pfizer boosts rare disease pipeline with $5.4B acquisition of Global Blood Therapeutics
The $5.4 billion deal marks Pfizer's fourth acquisition in the last nine months -
News Thermo Fisher Scientific announce expansion of cell culture media manufacturing site
The expansion of Thermo Fisher Scientific’s Grand Island, New York cell culture media manufacturing site offers increased redundant capacity in support of vaccine and biologic therapy development and manufacturing. -
News mRNA production partnership to scale-up COVID-19 vaccine development
GreenLight Biosciences and Samsung Biologics announce mRNA production partnership to scale mRNA vaccine production to a commercial level with Samsung's expanded mRNA drug substance manufacturing site. -
News Artificial intelligence used to uncover ‘dark matter of the plant kingdom’
Brightseed uses its AI-enabled platform to detect natural bioactives important to human health, also known as ‘nature’s dark matter’ -
News Taiwan’s TFBS partners with Univercells Technologies for use of bioreactor to develop GMP processes
TFBS will use Univercells’ scale-X™ carbo mid-scale fixed-bed bioreactor to support GMP viral vector operations -
News CureVac files patent infringement lawsuit against BioNTech over mRNA technology
Company is seeking ‘fair compensation’ for alleged infringement of intellectual property rights relating to the use of mRNA tech to create the Pfizer-BioNTech COVID-19 vaccine -
News WuXi STA launches new HPAPI production facility in China
The new plant features flow chemistry and milling technology, as well as reactors up to 3,000 liters -
News Charles River opens new UK manufacturing facility to support cell & gene development
The new facility is set to quadruple the company's HQ plasmid DNA capacity -
News WHO says monkeypox not a health emergency, but leaders ‘deeply concerned’
The UN agency convened a meeting last week to discuss the outbreak
-
News Valneva stock jumps as Pfizer invests more than €90M to support Lyme disease vaccine trial
VLA15 is the only Lyme disease vaccine candidate currently in clinical development -
News Tonix strives for pandemic readiness with new US manufacturing facility
The company's goal is to design and test new vaccines for novel pathogens within 100 days of a potential pandemic threat -
News WHO to consider whether monkeypox should be classed as health emergency
A committee will meet next week to discuss issuing the emergency designation. -
News Evotec enters drug discovery collaboration with Janssen Pharmaceutica NV
Evotec and Janssen Pharmaceutica team up to discover novel therapeutic candidates -
News BioNTech to start work on first African mRNA vaccine factory this month
The Rwanda site will be the first piece of the company’s African manufacturing network -
News Niche start-ups spearheading cell and gene therapy innovation
Smaller companies targeting rare and extremely specific treatment areas are leading the charge in this emerging market. -
News GSK to acquire clinical-stage biopharma company Affinivax
The $3.3 billion deal will strengthen GSK’s vaccine pipeline. -
News Western countries consider stockpiles, place orders for vaccine against monkeypox
The US, Canada, UK, France, Germany, and Spain are among several countries to purchase vaccine doses. -
News Integrated service partners outperform standalone CDMOs in clinical development – Thermo Fisher
Engaging an integrated services partner could reduce risk and speed-up the process for drug sponsors. -
News Bora Pharmaceuticals acquires biologics CDMO facility
Bora says the acquisition will allow it to rapidly build a presence in the biopharmaceuticals market. -
News Thermo Fisher and Charles River join consortium using robotics to produce cell therapies at scale
The Consortium aims to increase the scale of cell therapy manufacturing to a level impossible with current manual processes. -
News Private equity firm to acquire CDMO CordenPharma from ICIG
Astorg has agreed to acquire the CDMO from privately-owned industrial group ICIG -
News First SPAC focused on biopharma products launches in Europe
A special purpose acquisition company (SPAC) focused on absorbing companies that make medicines for the biotech and pharmaceutical industry has launched in Europe. -
News Africa’s first COVID-19 vaccine plant receives no orders since launch
The first COVID-19 vaccine plant in Africa is at risk of closure due to lack of demand. -
News Samsung Biologics fully acquires Samsung Bioepis for $2.3B
Samsung Biologics has full ownership over Samsung Bioepis after purchasing Biogen’s stake -
News UK first in Europe to approve Valneva's easy-store COVID-19 vaccine
The UK was the first European country to approve the vaccine from French firm Valneva -
News Samsung Biologics says Plant 4 to be partially operational by end of year
Construction of Plant 4 – dubbed Super Plant – will be complete in 2023 -
News Sanofi to list drug ingredients subsidiary EUROAPI on Euronext Paris
Sanofi will reduce its stake in EUROAPI to 30% after listing -
News UK project accelerates ATMP manufacturing supply chain
Symbiosis, Freeline Therapeutics and Cell and Gene Therapy Catapult joined forces to decrease drug manufacturing timelines -
News Fresenius agrees two acquisitions to expand Kabi drugs unit
The German healthcare group says the acquisitions will accelerate strategic growth in biopharmaceuticals and MedTech -
News US FDA gives green light to UCB’s drug for rare childhood epilepsy
The FDA also granted paediatric exclusivity to the oral solution, branded Fintepla. -
News Janssen invests €150M to expand Irish biopharmaceutical facility
The expansion will take two years and add 180 new jobs. -
News KKR-backed Biosynth Carbosynth acquires Vivitide
KKR closes its previously-announced acquisition of Biosynth Carbosynth and announces Biosynth's acquisition of vivitide. -
News Almac supports ATMP launches with expanded European facility
The CDMO has expanded its ultra-low temperature commercial packaging, labelling and distribution solutions facility in Ireland -
News Report reveals 2021 was another bumper year for biopharma deal-making
The largest sums of capital were awarded to US biotech companies, followed by companies based in Mainland China and the UK -
News Moderna to build first mRNA vaccine manufacturing facility in Africa
Moderna announces up to USD $500 million investment for the construction of mRNA vaccine manufacturing facility in Kenya, the first of its kind on the African continent. The facility will be a significant step towards vaccine equity... -
News Biomanufacturing Trends – Capacity, Capability and Careers
In this month's edition of the CPHI Webinar Series, experts from BioPlan Associates and NIBRT share insights on key trends impacting the biomanufacturing and bioprocessing sector. -
News OPTI-STEM Consortium receives financial boost to democratise access to cell therapy in France and Europe
Public funding of more than €7 million will help the project to find a solution to prohibitive production costs of developing stem cell-based therapies -
News Heidelberg Pharma and Huadong Medicine strike licensing and investment agreement
The multimillion-dollar deal focuses on potential targeted cancer treatments and makes Huadong the strategic partner in Asia for Heidelberg Pharma’s product development -
News CPHI Podcast Series: Securing the Biopharma Workforce of the Future
The biopharmaceutical industry has seen incredible growth in the past decade, and shows no sign of slowing as the need for specialised treatments in oncology, immunology and vaccines continue to grow. -
News Recipharm notches up two more niche CDMO acquisitions
The two transactions enable Recipharm to expand its ATMP offering into virotherapies and boost its US biologics services -
News Thermo Fisher Scientific Expands Millersburg, Pa. Bioprocessing Manufacturing Site
$40 million expansion will support increased production of single-use technology for critical vaccines and biologics -
News Emissions down and profits up: how can biopharma be more sustainable?
The biopharma industry drives development of complex therapies which improve the health outcomes and quality of life of patients across the globe. It is however a significant contributor to environmental waste and emissions as a direct result of it'... -
News Sustainability vs single-use-tech: how COVID-19 has made biopharma more sustainable
COVID-19 saw biopharma turn to single-use technology in a big way. But greater use of disposable manufacturing systems does not necessarily mean drug and vaccine production has become less environmentally sustainable. -
News 2022 — a turning point for US biosimilars?
Cardinal Health says the majority of healthcare providers are keen to use biosimilars despite current market challenges -
News Lilly to invest $1.5 billion in two new manufacturing sites
The $1.5 billion investment will fund a parenteral manufacturing facility in North Carolina and a biopharmaceutical manufacturing site in Ireland -
News Samsung Biologics to buy out Biogen's stake in Samsung Bioepis
Samsung Biologics has reached an agreement for the buyout of Biogen’s stake in the Samsung Bioepis joint venture for USD $2.3 billion. -
News WuXi Vaccines and BravoBio collaborate to accelerate innovative vaccines
The CDMO will provide expertise and capacity to advance BravoBio's vaccine pipeline -
News Watch now: Pharma Trends 2022 Webinar
We are approaching the end of a year which saw global vaccine rollout for COVID-19, 44 novel drug approvals (to date) and the return of the CPHI Worldwide in-person event. -
News Piramal adds antibody CDMO capabilities with investment in Yapan Bio
Transaction adds new technologies and capabilities in large molecules, including vaccines and gene therapy, to its global offering -
News Samsung Biologics and AstraZeneca expand manufacturing partnership to include COVID-19 and cancer therapies
CDMO currently manufacturing LAAB combination treatment and will start on cancer immunotherapy product from next year -
News Oxford Biomedica and Novartis extend lentiviral vector manufacturing agreement
The new agreement extends to 2028 and allows Oxord Biomedica to work with other potential partners across all CAR-T targets
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance